Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1680, 2015, Pages

  Whiting, Paul ^a   Kerby, Julie ^a   Coffey, Peter ^b   da Cruz, Lyndon ^b   McKernan, Ruth ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Pluripotent stem cell; Regenerative medicine; Retina

Indexed keywords

CELLS AND CELL COMPONENTS; EMBRYONIC DEVELOPMENT; HUMAN ACTIVITY; MEDICINE; REPLACEMENT; TECHNOLOGY;

ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; MACULAR DEGENERATION; REGENERATIVE MEDICINE; RETINAL PIGMENT EPITHELIUM; TRANSLATIONAL RESEARCH; TRANSPLANTATION; TRENDS;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; EMBRYONIC STEM CELLS; HUMANS; MACULAR DEGENERATION; REGENERATIVE MEDICINE; RETINAL PIGMENT EPITHELIUM; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84942940740     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0375     Document Type: Article

References (33)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998 Embryonic stem cell lines derived from human blastocysts. Science 6, 1145–1147. (doi:10.1126/science.282.5391.1145)
2. Lebkowski J. 2011 GRNOPC1: the world’s first embryonic stem cell-derived therapy. Interview with Jane Lebkowski. Regen. Med. 6, 11–13. (doi:10.2217/rme.11.77)
3. Scott C, Huggett B. 2012 Geron’s quixotic fate. Nat. Biotechnol. 30, 497. (doi:10.1038/nbt.2253)
4. Schwartz SD et al. 2014 Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 6736, 61376–61383. (doi:10.1016/S0140-6736(14)61376-3)
5. Park K-M, Kim H-J, Lee JH, Choi J, Young Chong S, Shim SH, Del Priore LV, Lanza R. 2015 Treatment of macular degeneration using human embryonic stem cell derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Rep. 4, 860–872. (doi:10.1016/j.stemcr.2015.04.005)
6. Reardon S, Cyranoski D. 2014 Japan stem cell trial stirs envy. Nature 513, 287–288. (doi:0.1038/513287a)
7. Stein-Streilein J. 2013 Mechanisms of immune privilege in the posterior eye. Int. Rev. Immunol. 32, 42–56. (doi:10.3109/08830185.2012.740535)
8. Detrick B, Hooks JJ. 2010 Immune regulation in the retina. Immunol. Res. 47, 153–161. (doi:10.1007/s12026-009-8146-1)
9. Cook HL, Patel PJ, Tufail A. 2008 Age-related macular degeneration: diagnosis and management. Br. Med. Bull. 85, 127–149. (doi:10.1093/bmb/ldn012)
10. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P. 2007 RPE transplantation and its role in retinal disease. Prog. Retin. Eye Res. 26, 598–635. (doi:10.1016/j.preteyeres.2007.07.001)
11. Sparrow JR, Hicks D, Hamel CP. 2010 The retinal pigment epithelium in health and disease. Curr. Mol. Med. 10, 802–823. (doi:10.2174/156652410793937813)
12. Tzameret A et al. 2014 Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy. Exp. Eye Res. 118, 135–144. (doi:10.1016/j.exer.2013.10.023)
13. Chen FK, Uppal GS, MacLaren RE, Coffey PJ, Rubin GS, Tufail A, Aylward GW, Da Cruz L. 2009 Longterm visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin. Exp. Ophthalmol. 37, 275–285. (doi:10.1111/j.1442-9071.2009.01915.x)
14. Chen FK, Patel PJ, Uppal GS, Rubin GS, Coffey PJ, Aylward GW, Da Cruz LA. 2009 Comparison of macular translocation with patch graft in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 50, 1848–1855. (doi:10.1167/iovs.08-2845)
15. Muthiah MN, Keane PA, Zhong J, Gias C, Uppal G, Coffey PJ, da Cruz L. 2014 Adaptive optics imaging shows rescue of macula cone photoreceptors. Ophthalmology 121, 430–431. (doi:10.1016/j.ophtha.2013.10.008)
16. Carr AJ et al. 2009 Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol. Vis. 15, 283–295.
17. Vugler A et al. 2008 Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol. 214, 347–361. (doi:10.1016/j.expneurol.2008.09.007)
18. Salero E, Blenkinsop TA, Corneo B, Harris A, Rabin D, Stern JH, Temple S. 2012 Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 10, 88–95. (doi:10.1016/j.stem.2011.11.018)
19. Choudhary P, Dodsworth B, Sidders B, Gutteridge A, Michaelides C, Duckworth J, Whiting P, Benn C. 2015 A FOXM1 dependent mesenchymal–epithelial transition in retinal pigment epithelium cells. PLoS ONE 10, e0130379. (doi:10.1371/journal.pone.0130379)
20. Hsiung J, Zhu D, Hinton DR. 2015 Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Stem Cells Transl. Med. 4, 10–20. (doi:10.5966/sctm.2014-0205)
21. Sugino IK et al. 2011 Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch’s membrane. Invest. Ophthalmol. Vis. Sci. 52, 4979–4997. (doi:10.1167/iovs.10-5386)
22. Diniz B et al. 2013 Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest. Ophthalmol. Vis. Sci. 54, 5087–5096. (doi:10.1167/iovs.12-11239)
23. Velez-Montoya R, Oliver SC, Olson JL, Fine SL, Quiroz-Mercado H, Mandava N. 2014 Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina 34, 423–441. (doi:10.1097/IAE.0000000000000036)
24. Smith AG, Kaiser PK. 2014 Emerging treatments for wet age-related macular degeneration. Expert Opin. Emerg. Drugs 19, 157–164. (doi:10.1517/14728214.2014.884559)
25. Jackson GS et al. 2014 Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol. 71, 421–428. (doi:10.1001/jamaneurol.2013.6001)
26. Närvä E et al. 2010 High-resolution DNA analysis of human embryonic stem cell lines reveals cultureinduced copy number changes and loss of heterozygosity. Nat. Biotechnol. 28, 371–377. (doi:10.1038/nbt.1615)
27. Nelakanti RV, Kooreman NG, Wu JC. 2015 Teratoma formation: a tool for monitoring pluripotency in stem cell research. Curr. Protoc. Stem Cell Biol. 32, 4A81–4A817. (doi:10.1002/9780470151808.sc04a08s32)
28. Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. 2012 Lessons from human teratomas to guide development of safe stem cell therapies. Nat. Biotechnol. 30, 849–857. (doi:10.1038/nbt.2329)
29. Gropp M et al. 2012 Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. PLoS ONE 7, e45532. (doi:10.1371/journal.pone.0045532)
30. Cooke MJ, Stojkovic M, Przyborski SA. 2006 Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. Stem Cells Dev. 15, 254–259. (doi:10.1089/scd.2006.15.254)
31. Studer L. 2012 Derivation of dopaminergic neurons from pluripotent stem cells. Prog. Brain Res. 200, 243–263. (doi:10.1016/B978-0-444-59575-1.00011-9)
32. Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA. 2014 Generation of functional human pancreatic b cells in vitro. Cell 159, 428–439. (doi:10.1016/j.cell.2014.09.040)
33. Shi Y, Kirwan P, Livesey FJ. 2012 Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat. Protoc. 7, 1836–1846. (doi:10.1038/nprot.2012.116)